visceral fat obesity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) age between 30 and 70 years old at consent 2) waist circumference >=85 cm (man), >=90 cm (woman) 3) subjects understand the study procedures and agree to participate in the study by giving informed consent prior to the study.
Exclusion criteria
Exclusion criteria: 1) experienced body weight changes >= 10% within a year before the start date of this study 2) attended another clinical study within a month before the start date of this study 3) Fasting blood sugar >=126 mg/dl or HbA1c (NGSP) >=6.5% or diabetic patient 4) has history of serious cardiovascular diseases 5) has history of surgery in gastrointestinal tract 6) takes drugs to treat dyslipidemia 7) has continuous intake of dietary fiber supplement or beta glucan (barley, mushroom, black yeast, etc) 8) has continuous intake of Divaricate Saposhnikovia Miraculous Powder 9) has serious liver or kidney disease 10) has history of malignant diseases 11) has serious infectious diseases 12) pregnant or lactating woman 13) allergic to raw materials 14) is not appropriate in the investigator's opinion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| change in visceral fat area | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) body weight, waist circumference, subcutaneous fat area, total fat area 2) total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol 3) HbA1c, insulin, free fatty acid, fasting blood sugar 4) leptin, adiponectin 5) blood pressure 6) questionnaire survey about eating behavior and psychosomatic state | — |
Countries
Japan
Contacts
Osaka city University Hospital Center for Drug & Food Clinical Evaluation